- Home
- JAZZ vs IREN Comparison
JAZZ vs IREN Comparison
Compare JAZZ & IREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JAZZ | IREN |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | Ireland | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 16.0B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JAZZ | IREN |
|---|---|---|
| Price | $239.79 | $46.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $217.57 | $62.50 |
| AVG Volume (30 Days) | 877.4K | ★ 34.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.17 | N/A |
| Revenue | ★ $1,618,693,000.00 | $707,007,000.00 |
| Revenue This Year | $6.22 | $104.58 |
| Revenue Next Year | $7.68 | $200.20 |
| P/E Ratio | $34.01 | ★ N/A |
| Revenue Growth | N/A | ★ 41.11 |
| 52 Week Low | $125.79 | $28.93 |
| 52 Week High | $266.38 | $76.87 |
Technical Indicators
Market Signals| Indicator | JAZZ | IREN |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 58.26 |
| Support Level | $236.70 | $46.00 |
| Resistance Level | $242.66 | $48.66 |
| Average True Range (ATR) | 5.77 | 2.62 |
| MACD | -0.36 | 0.34 |
| Stochastic Oscillator | 32.04 | 77.31 |
Price Performance
Historical ComparisonAbout JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About IREN Iris Energy Limited
IREN owns data centers powered by renewable energy in Canada and the US for bitcoin mining and AI cloud infrastructure. The company is in the process of converting its existing bitcoin capacity for AI purposes and securing new power and land supply to expand its data center operation. IREN works closely with industry leaders in AI, such as Microsoft, to support their cloud infrastructure ambitions.